Understanding the molecular basis of interaction specificity between RGS (regulator of G protein signaling) proteins and heterotrimeric () G proteins would enable the manipulation of RGS-G protein interactions, explore their functions, and effectively target them therapeutically. RGS proteins are classified into four subfamilies (R4, R7, RZ, and R12) and function as negative regulators of G protein signaling by inactivating G subunits. We found that the R12 subfamily members RGS10 and RGS14 had lower activity than most R4 subfamily members toward the G i subfamily member G o . Using structure-based energy calculations with multiple G-RGS complexes, we identified R12-specific residues in positions that are predicted to determine the divergent activity of this subfamily. This analysis predicted that these residues, which we call "disruptor residues," interact with the G helical domain. We engineered the R12 disruptor residues into the RGS domains of the high-activity R4 subfamily and found that these altered proteins exhibited reduced activity toward G o . Reciprocally, replacing the putative disruptor residues in RGS18 (a member of the R4 subfamily that exhibited low activity toward G o ) with the corresponding residues from a high-activity R4 subfamily RGS protein increased its activity toward G o . Furthermore, the high activity of the R4 subfamily toward G o was independent of the residues in the homologous positions to the R12 subfamily and RGS18 disruptor residues. Thus, our results suggest that the identified RGS disruptor residues function as negative design elements that attenuate RGS activity for specific G proteins.
INTRODUCTION
Heterotrimeric guanine nucleotide-binding proteins (G proteins) play a critical role in countless physiological processes, functioning as molecular switches in intracellular signal transduction pathways (1, 2) . The G subunit determines the activation state of the G protein switch, cycling between a guanosine diphosphate-bound inactive state and a guanosine 5′-triphosphate (GTP)-bound active state that mediates downstream signaling. The duration of heterotrimeric G protein signaling is controlled by RGS (regulator of G protein signaling) proteins that inactivate G subunits (3) (4) (5) (6) . This "turn off" function of RGS proteins is achieved by allosterically accelerating GTP hydrolysis in the G subunits. This allosteric regulation is mediated by the ~120-amino acid "RGS domain," which is present in all RGS proteins and is responsible for the function of RGS proteins as guanosine triphosphatase (GTPase)-activating proteins (GAPs) (4, 5, 7) . As expected from their key role in G protein-coupled signaling, RGS proteins mediate numerous physiological functions, are involved in a wide range of human pathologies, and are considered promising drug targets (8) (9) (10) (11) (12) .
Proteins with RGS domains represent a large and diverse family. Of these, the 20 "classical" or "canonical" RGS proteins can recognize and inactivate G subunits that belong to the G i and G q subfamilies. Canonical RGS proteins have been further divided into four subfamilies (R4, R7, RZ, and R12) based on their sequence similarity (13) . The R4 subfamily is the largest, consisting of 10 members: RGS1, RGS2, RGS3, RGS4, RGS5, RGS8, RGS13, RGS16, RGS18, and RGS21 (8, 12, 13) . With the noted exception of RGS2, which has no activity toward G i subfamily members (14) (15) (16) , members of the R4 subfamily are generally considered to have high GAP activity toward the G i subfamily, with well-studied examples including RGS1 (17, 18) , RGS4 (18) (19) (20) , and RGS16 (18, (21) (22) (23) . The R12 subfamily (RGS10, RGS12, and RGS14) is implicated in a range of physiological processes or pathologies. RGS10 is suggested to be involved in cardiovascular diseases (24) , platelet function (25) , macrophage activation (26), Parkinson's disease (27) , and chemoresistance in ovarian cancer (28) . RGS12 is implicated in neuron and bone differentiation (29, 30) , cardiac hypertrophy, and heart failure (31) . RGS14 is abundant in the brain and is involved in spatial memory and learning (32, 33) , cell division and chemotaxis (34, 35) , and Parkinson's disease (36) . Therefore, the R12 subfamily members attract considerable attention both as physiological modulators of signaling and as potential drug targets. However, their cellular targets and the exact role that their GAP function plays in these cascades are unknown.
Although R12 subfamily members were suggested to act as specific GAPs toward the G i subfamily (37) , previous studies reported different relative GAP activities for this subfamily. For example, the RGS10 RGS domain has high activity toward G i (5) , and its GAP activity is higher toward G i and G z than is the activity of other RGS proteins, such as RGS19 and RGS4 (38) . Compared to high-activity RGS proteins, such as RGS4 and RGS16, RGS12 (39, 40) and RGS14 (18, 41, 42) exhibit lower GAP activity toward G i . Other studies measured high GAP activity of RGS14 toward both G o and G i (43) or reported that RGS14 has a higher GAP activity than that of RGS4 toward G o and G i (44, 45) . Therefore, quantification of the GAP activities of this R12 subfamily in relation to those of R4 family members is lacking, as is an understanding of which amino acids determine R12 GAP activity toward the G i subfamily.
The structural basis for the GAP activity and the selectivity of RGS domains is of great interest yet is only partially understood. To accelerate the GTPase activity of the G subunit, the RGS domain binds to the G-GTP complex and allosterically stabilizes the G catalytic machinery in its transition state conformation (12, 13, 21, (46) (47) (48) (49) .
In all of the structures of G-RGS complexes solved to date, the RGS domain binds mainly to the GTPase domain of the G subunit (16, 37, 46, (50) (51) (52) (53) . However, several of these structural studies report RGS interactions with another G domain, the G helical domain (37, (51) (52) (53) . In the G protein superfamily, the G helical domain is found only in the G subunits of heterotrimeric G proteins, and for many years, the purpose of the G helical domain was unclear. Suggested functional roles included increasing the affinity of the G protein for GTP (54) , acting as an intrinsic GAP (55), or participating in effector recognition (56) . The G helical domain is implicated in binding to inhibitory proteins, such as those with the GoLoco motif (57) (58) (59) , and in catalyzing nucleotide exchange and G activation by G protein-coupled receptors (60) . The previous structural studies of G-RGS complexes suggest that RGS contacts with the G helical domain are variable and heterogenic, properties consistent with this domain contributing to interaction specificity (37, 51) . Structural studies of RGS2 and RGS8 bound to G q also indicated that interactions with its G helical domain might play a role in dictating affinity or GAP "potency," the relative GTPase-accelerating activity of RGS proteins (52, 53) . Together, these studies raise two interconnected questions. First, are RGS domain interactions with the G helical domain functionally important for RGS GAP activity? Second, how might these interactions encode specificity among members of the RGS family?
In a previous study, we used energy calculations to analyze structures of RGS domains with G subunits from the G i subfamily (18) , identifying which RGS residues contribute substantially to interactions with these G subunits. We further classified these G-interacting RGS residues into two groups. The first group contains "Significant & Conserved" (S&C) residues, which make similar and substantial energy contributions across all available structures. These residues make most of the interactions with the residues adjacent to the G catalytic site and presumably have a primary role in accelerating G GTPase activity by stabilizing G in a conformation optimal for GTP hydrolysis (1, 12, 49, 61) . The second group contains "Modulatory" residues, which make substantial energy contributions only in some of the structures and are not conserved across all of the RGS domains. Modulatory residues are located at the periphery of the RGS domain interface with G subunits. We proposed that modulatory residues encode specific interactions with particular G subunits (18) . Substitution of such modulatory residues in low-activity RGS proteins with their counterparts from high-activity RGS domains showed that these modulatory residues encode RGS selectivity in the RZ and R4 subfamilies. The hypothesis that emerged from this study is that RGS modulatory positions determine interaction specificity with G subunits. Yet, the mechanistic details of this putative role are lacking.
Here, we evaluated the relative GAP activities of R12 and R4 subfamily members toward the representative G i subfamily member G o . We found that, compared to the high-activity R4 subfamily members RGS4 and RGS16, the R12 subfamily members RGS10 and RGS14 had lower GAP activity toward G o . Using structure-based computations, we identified R12-specific residues in modulatory positions that may be responsible for these differences in GAP activity. We analyzed these residues at the three-dimensional (3D) structural level and predicted that they interact with the G helical domain. We validated our computational predictions through mutagenesis of R4 and R12 RGS domains. Introducing the modulatory residues from R12 subfamily members into high-activity R4 subfamily members converted them into RGS proteins with low GAP activity toward G o , whereas replacing the modulatory residues in R12 subfamily members with low GAP activity toward G o resulted in higher GAP activity toward this G subunit. Together, our results suggest that the R12-specific disruptor residues that we identified function as negative modulatory elements that attenuate RGS GAP activity in a specific fashion.
RESULTS

R12
subfamily members show lower GAP activity toward G o compared to that of high-activity RGS domains We compared the GAP activities of RGS10 and RGS14, which are members of the R12 subfamily, with the activity of RGS16 and RGS4, which are representative members of the R4 subfamily with high activity toward the G i subfamily (18, 20, 21, 23, 62) . We used singleturnover GTPase assays with G o and a catalytic concentration of RGS proteins to calculate the catalytic rate (k GAP ) of the four RGS proteins according to previously published methodology (48, 63, 64) . RGS10 and RGS14 had lower GAP activities toward G o (k GAP = 0.5 and 0.3 min −1 , respectively), and RGS16 and RGS4 had higher GAP activities (k GAP = 1.3 and 1.3 min −1 , respectively) (Fig. 1A) . We also measured the GAP potency (52, 65) , the concentration of RGS protein that produced a 50% maximal increase in GTP hydrolysis [halfmaximal effective concentration (EC 50 )], of RGS10, RGS14, and RGS16 (Fig. 1B) . In this in vitro assay, RGS16 had a higher GAP potency than those of RGS10 and RGS14 (RGS16 EC 50 = 7 nM; RGS10 EC 50 = 42 nM; RGS14 EC 50 = 63 nM). We then turned to energy-based analysis to identify which R12 residues might determine the lower GAP activities of these R12 subfamily members.
Energy calculations predict that R12-specific residues in modulatory positions perturb productive interactions with the G helical domain On the basis of the methodology that we developed previously (18) , we can use energy-based calculations to identify which RGS residues contribute substantially to interactions with G subunits. We analyzed four x-ray complexes of G subunits bound to three different RGS domains from R4 subfamily members with high GAP activity toward the G i subfamily: RGS1, RGS4, and RGS16 (see Materials and Methods). Two of the complexes are of RGS16, which was solved in complexes with G i and G o (37, 51) . We used the A B S1 ). We classified RGS S&C and modulatory residues (18) and visualized them on the superimposed structures of these four complexes ( Fig. 2A) . Our analysis showed that RGS S&C residues interact only with the GTPase domain in all four structures. In contrast, we found that RGS modulatory residues interact both with the GTPase domain and with the G helical domain. Using the structures of G i with RGS16 ( Fig. 2B ) and RGS4 (Fig. 2C) , we identified four modulatory residues in each RGS protein that interacted with the G helical domain. In RGS16, the modulatory residues Glu , which is unique to RGS4 among all classical RGS proteins (and corresponds to Pro 169 in RGS16), contributed substantially to the interaction with the G helical domain.
To identify which R12 subfamily residues are responsible for the low GAP activity of these RGS proteins toward G o , we mapped the results of our energy analysis onto the sequences of the representative R4 subfamily members and compared them to the sequences of the R12 RGS domains (Fig. 3) . Using the available crystal structures of high-activity RGS proteins with G i1 and G o , we examined which substitutions of R4 residues in the R12 subfamily might hinder interactions with G subunits. Our analysis predicted that the contribution of all S&C residues is conserved across these R4 subfamily members ( Fig. 3A) and across the three R12 subfamily members (Fig. 3B ). Although most of the RGS modulatory residues were predicted to contribute similarly across the R12 subfamily and were thus classified as conserved modulatory residues (Fig. 3B) , four modulatory positions were markedly different. Three of these residues, which we termed putative "disruptor" residues, are located in modulatory positions, are specific to the R12 subfamily, and were predicted to perturb the favorable interactions found in the R4 subfamily complexes with G subunits. In RGS16, these three modulatory positions (Glu 135 , Glu
164
, and Lys
165
) interact with the G helical domain (Fig. 2B) . The residues corresponding to RGS16 Glu 164 and Lys 165 are conserved in RGS4 and RGS1 (Fig. 3A) . However, our structural analysis indicated that there is no contribution in RGS4 from Cys 132 (Fig. 2C) , which is the position that corresponds to RGS16 Glu 135 . Rather, Arg 166 , which is unique to RGS4, is predicted to contribute to interactions with the helical domain. We note that an arginine in this position is unique to RGS4 among all RGS family members. The last RGS modulatory position that, according to our calculations, interacts with the G helical domain (Lys 173 in RGS16 and Lys 170 in RGS4) is identical across the R4 and R12 subfamilies ( Fig. 3 ) and is therefore not likely to contribute to their specificity toward G subunits.
Analyzing the structural differences between these R12 residues and the corresponding residues in high-activity R4 subfamily members suggested a mechanistic basis for the lower GAP activity of the R12 subfamily. We superimposed the structures of RGS16-G i1 and RGS16-G o and visualized the modulatory RGS16 residues Glu 135 , Glu 164 , and Lys 165 and their interacting partner residues in the G subunit (Fig. 4A) . In the high-activity RGS16 protein, Lys 165 forms an electrostatic and hydrogen bond network with multiple residues on both sides of the interface-an intramolecular salt bridge with RGS16 Glu 164 , an intermolecular salt bridge with G i1 Glu 116 (located in the B-C loop), and a hydrogen bond with G i1 Ser 75 ( Fig. 4A,  top) . We observed a similar interaction network in the complexes of G i1 with RGS1 and RGS4 ( fig. S2 ). One interaction that we observed in the structural analysis that was not predicted from the energy calculations was the electrostatic contributions of Lys 165 to the interactions with G i1 . Because we calculated the energy difference between the monomers and the complex structures, which correspond to the net electrostatic contributions to affinity in the complex, we interpreted the former result to mean that the Lys 165 -mediated electrostatic network plays an allosteric role in RGS GAP activity rather than contributes to an increased RGS-G affinity. Moreover, the conformation of the B-C loop differs between G i1 and G o . Nevertheless, the corresponding residue to G i1 Glu 116 in G o , Asp
116
, forms a similar electrostatic interaction with RGS16 Lys 165 (Fig. 4A, top) .
Modeling the corresponding residues in RGS10 and RGS14 suggested that they perturb interactions with the G helical domain. We superimposed the structures of RGS10 and RGS14 on the structures of the RGS16-G i1 and RGS16-G o complexes (Fig. 4B, top) . This revealed that the KY (RGS10) and KF (RGS14) motifs cannot form the electrostatic and hydrogen-bond network found in the G complexes with high-activity RGS domains ( (Fig. 4A, bottom) . The corresponding residues in RGS10 (Gln 103 ) and RGS14 (Gln 86 ) cannot form such an intermolecular salt bridge (Fig. 4B, bottom) . In G o , the basic residue (Arg 86 ) that interacts with the RGS16 Glu 135 originates one helix turn earlier than does Arg 90 in G i1 . However, the guanidino groups of both basic G residues occupy essentially the same position and interact similarly with RGS16 Glu
135
. The corresponding R12 glutamine residue is predicted to disrupt this interaction with both G i1 and G o (Fig. 4B, bottom) . The unique Arg 166 residue in RGS4 forms a salt bridge with G i1 Glu 116 (Fig. 4C) . The corresponding RGS10 Ser 136 and RGS14 Ala 119 residues cannot form such an intermolecular salt bridge (Fig. 4D) . Together, these data suggest that the three putative disruptor residues in either RGS10 or RGS14 are predicted to have a similar negative effect on the interactions of these RGS domains with both G o and G i1 .
Looking across the R4 subfamily, we identified RGS18 as a unique member with putative disruptor residues in the same positions as the R12 putative disruptor residues. In the position that corresponds to RGS16 Lys 165 (Fig. 4A ), RGS18 has a glutamine (Gln
186
). Similar to the R12 KY and KF motifs, Gln 186 is predicted to perturb the electrostatic network with the G helical domain residues (Fig. 4E, left; see also Fig. 4B, top) . In the position that corresponds to RGS16 Glu 135 (Fig. 4A, bottom) , RGS18 has a histidine (His
156
) that, similar to the R12 residues in this position, cannot form an intermolecular salt bridge with the G helical domain residues (Fig. 4E, right) . These results suggest that RGS18 contains the same putative disruptor elements as those of the R12 subfamily.
Inserting R12 putative disruptor residues into high-activity R4 subfamily members impairs their GAP activity To examine whether the R12 putative disruptor residues that we identified are responsible for the lower GAP activities of RGS10 and RGS14, we inserted them into high-activity R4 subfamily members. We replaced all three or pairs of the corresponding RGS16 residues (Glu 135 , Glu ) and measured the GAP activities of these mutants using single-turnover GTPase assays. On the basis of our structural comparison (Fig. 4, A and B) , we hypothesized that substituting the RGS16 Glu 164 -Lys 165 motif would have a more substantial effect on GAP activity than would substituting RGS16 Glu 135 with the corresponding R12 glutamine motif. Substituting the RGS16 Glu 164 -Lys 165 motif with the RGS10 putative disruptor residues [to generate the RGS16 E164K-K165Y (EK>KY) mutant] reduced its GAP activity (Fig. 5A) . The additional E135Q substitution (to generate the EEK>QKY mutant) did not further reduce GAP activity. When we substituted the RGS16 E164-K165 motif with the corresponding putative disruptor residues from RGS14, the RGS16 E164K-K165F (EK>KF) mutant exhibited a larger impairment in GAP activity than did the EK>KY mutant (Fig. 5A) . The larger effect of the RGS14 disruptor residues, compared to that of the RGS10 residues, recapitulated the lower GAP activity of RGS14 compared to that of RGS10 (Fig. 1) . In contrast with the EEK>QKY mutant, adding the E135Q mutation to the E164K-K165F mutant (EEK>QKF) further reduced GAP activity. As expected from the similarity of the disruptor motifs in the structures of RGS10, RGS14, and RGS18 (Fig. 4, B and E Residue-level sequence map summarizing our structure-based energy calculations of the R4 representative complexes with G subunits. Colored boxes mark RGS residues that contribute substantially to interactions with G subunits, according to the type of energy contribution: nonpolar (np), electrostatic (elec) contributions from the residue side chain (sc elec) or the main chain (mc elec). S&C residues for all four R4 structures are marked with red asterisks above the alignment, and modulatory positions that contribute in any of the four R4 structures are marked with purple triangles. An open star symbol marks modulatory RGS residues that contribute to interactions with the G helical domain across all of the analyzed high-activity R4 subfamily members; a black circle marks a contribution found only in some R4 high-activity representatives. The numbering above the alignment is according to the human RGS16 sequence. (B) Sequence-based prediction of R12 subfamily residue-level contributions, classified into three groups: Conserved S&C residues and conserved modulatory residues are residues that are identical across the relevant R4 and R12 subfamilies members; putative disruptor residues are R12-specific residues in modulatory positions that are different than their counterparts in the high-activity R4 subfamily and are predicted to impair the interaction with the G helical domain. also impaired GAP activity (Fig. 5A ). In contrast, mutation of adjacent residues that were not predicted to contribute as much to the interaction between RGS16 and G, such as RGS16 residues (Tyr 168 and Pro 169 to Ala), did not impair GAP activity. Tyr 168 is conserved across most RGS domains and is present in all high-activity R4 subfamily members and in all R12 subfamily members. Pro 169 is conserved across all high-activity R4 subfamily members, with the exception of RGS4, in which the corresponding Arg 166 is a unique contributing modulatory residue (Fig. 4C) . In RGS14, the corresponding residue is an alanine (Fig. 4D) . As expected from our energy calculations indicating that these two conserved residues do not contribute to interactions with G subunits (Fig. 3) , the Y168A and the P169A mutants exhibited similar GAP activities to that of wild-type (WT) RGS16 (Fig. 5A) .
In a reciprocal experiment, we replaced the RGS10 or the RGS14 putative disruptor residues with their RGS16 counterparts, which reduced GAP activity ( fig. S3 ). The R12 subfamily has an adjacent heterogeneous structural region in the extended V-to-VI loop (37) . We predict that this region will likely affect the local conformation of the R12 subfamily members. Therefore, we hypothesized that this heterogeneity does not enable substituted residues to reach the exact conformation seen in RGS16 or RGS4 (Fig. 4A and  fig. S2 ). Thus, substituting only the two or three modulatory residues would be insufficient to convert the RGS10 and RGS14 proteins into high-activity GAPs. However, an RGS14 chimera in which we substituted all RGS14 residues that can affect regions V to VI and VII, which contain the three RGS14 disruptor residues Gln 86 , Lys
114
, and Phe
115
, with their RGS16 counterparts, resulted in a protein with increased GAP activity compared to that of WT RGS14 ( fig. S3) .
Dose-response analysis of the GAP potencies of the RGS16 EEK> QKY and EEK>QKF mutants indicated that the GAP potency of these mutants was reduced (Fig. 5B) . The EC 50 of the EEK>QKY mutant was 26 nM, and the EC 50 of the EEK>QKY mutant was 73 nM, whereas the EC 50 of WT RGS16 was 7 nM (Fig. 5B) . Therefore, these RGS16 mutants had a comparably reduced GAP potency, which was similar to that of RGS10 and RGS14. Similar to the RGS16 mutants, replacing the putative R12 subfamily disruptor residues in the corresponding positions of RGS4 reduced GAP activity (Fig. 5C) , with the corresponding RGS14 putative disruptor residues (to generate RGS4 E161K-K162F, the EK>KF mutant) substantially reduced GAP activity. Adding a substitution of the unique RGS4 Arg 166 with its RGS14 counterpart to generate the triple mutant, RGS4 E161K-K162F-R166A (EKR>KFA), further reduced GAP activity. The k GAP of this RGS4 triple mutant (0.2 min ; Fig. 1A ). In comparison, mutating the RGS4 S&C residue Asn 128 , which is essential for RGS catalytic activity (18, 21, 48) , completely abolished RGS4 GAP activity (Fig. 5C) .
To test whether RGS16 residues Glu (Fig. 2B) , are necessary for its high GAP activity, we mutated all four residues to alanines. The resulting RGS16-Ala 4 mutant had similar GAP activity to that of WT RGS16 (Fig. 6) , suggesting that these residues are not essential for the high GAP activity of RGS16. This result indicates that alanines in these positions are permissible for high GAP activity; however, as we showed earlier, substituting the disruptor residues from low-activity RGS proteins, such as R12 family members, was not permissible for high GAP activity.
Replacing the putative RGS18 disruptor residues with their RGS16 counterparts increases GAP activity
To test whether substituting disruptor residues in the lowactivity protein RGS18 with their high-activity RGS counterparts removes the negative effect on GAP activity, we replaced the RGS18 disruptor residues with their RGS16 counterparts (Fig. 7) . The RGS18 Q186K mutant had increased GAP activity toward G o . The RGS18 H156E-Q186K double mutant had further increased GAP activity, which was comparable to that of WT RGS16. Therefore, these data suggest that replacing these RGS18 disruptor residues with their RGS16 counterparts is sufficient for a complete gain of function.
DISCUSSION
The broad challenge of deciphering protein-protein interaction specificity is particularly relevant to the interactions of RGS proteins with G subunits. Because numerous RGS proteins are usually coexpressed in a given cell, identifying the molecular design principles that determine selective recognition of G subunits by RGS proteins is essential for understanding which RGS proteins mediate particular physiological functions and for manipulating these interactions with drugs. However, which RGS-G interactions occur and which residues encode the specificity of these interactions are mostly unclear, which is partially due to the low sequence identity among RGS domains (as low as 30%). Such low sequence identity increases the difficulty of pinpointing which residues contribute to similar interactions and which residues determine interaction selectivity. However, quantitative structure-based approaches, such as the approach we used here, can pinpoint which residues contribute substantially to interactions across a protein family and guide mutagenesis to redesign RGS interactions with G subunits.
Looking beyond the RGS family, specific protein-protein interactions between families of signaling proteins are crucial for the C A B Fig. 5 . Replacement of RGS16 and RGS4 modulatory residues that interact with the G helical domain with the corresponding putative disruptor residues impairs GAP activity toward G o . (A) k GAP constants for WT RGS16 and the following RGS16 mutants: RGS16-to-RGS10 mutants E164K-K165Y (EK>KY) and E135Q-E164K-K165Y (EEK>QKY); RGS16-to-RGS14 mutants E164K-K165F (EK>KF) and E135Q-E164K-K165F (EEK>QKF); the RGS16-to-RGS18 mutant E135H-K165Q (E-K>H-Q); and the RGS16 mutants in noncontributing residues adjacent to Glu 164 and Lys
165
, Y168A and P169A. The k GAP values are means ± SEM of at least three independent biological replicates. (B) Dose-response analysis of WT RGS16, the EEK>QKY mutant, and the EEK>QKF mutant GAP activity toward G o . EC 50 values (RGS16 = 7 ± 1 nM; EEK>QKY = 26 ± 2 nM; EEK>QKF = 74 ± 3 nM) are means ± SEM of experiments performed in triplicate and are representative of at least three independent biological replicates each. (C) k GAP constants for WT RGS4 and the following RGS4 mutants: RGS4-to-RGS14 mutants E161K-K162F and E161K-K162F-R166A and the RGS4 S&C residue mutant N128S. k GAP values are means ± SEM of at least three independent biological replicates.
wiring of signaling networks. Useful terms to define structural elements that determine such specific interactions were coined by the protein design field: "Positive design elements" stabilize favorable interactions that strengthen particular protein pairings, whereas "Negative design elements" introduce unfavorable interactions that limit selected interactions between some family members (66, 67) . In particular, negative design elements are critical specificity determinants among well-studied examples in protein-protein interactions, such as heterodimeric coiled-coil pairs (68, 69) , colicin-immunity protein interactions (70, 71) , -lactamase and its protein inhibitors (72) , and Bcl-2 receptors binding to BH3-only proteins (73) .
Previous studies identified RGS residues that are crucial positive design elements for RGS GAP function (18, 21, 47, 48, 51, 74) . We classified most of these previously studied RGS residues as S&C residues (Fig. 2A) . These RGS residues interact with G residues adjacent to its catalytic site and presumably have a primary role in accelerating the GTPase activity of a G subunit by stabilizing a conformation that is optimal for GTP hydrolysis (1, 12, 21, 48, 49, 74) . However, to achieve high GAP activity, RGS domains also require sufficient modulatory residues that function as positive design elements. We had also suggested that modulatory residues encode specific interactions with particular G subunits (18) .
Here, we found that R12 subfamily "disruptor residues" function as negative design elements by means of interacting with the G helical domain. Our results demonstrate that the R12 subfamily members RGS10 and RGS14 have reduced GAP activity toward G o compared to the high-activity RGS proteins, such as RGS4 and RGS16. Our structure-based analysis identified three R12 positions as critical for this phenotype. Mutating the corresponding RGS16 and RGS4 modulatory residues to their R12 counterparts reduced the GAP activities of RGS16 and RGS4 to those of RGS10 and RGS14. Because the S&C and modulatory residues of RGS12 are essentially identical to those of RGS14, and in particular, because their putative disruptor residues are identical, we suggest that these RGS domains will have similar GAP activity and specificity and that our results may be applicable to the entire R12 subfamily. Moreover, because mutating these residues in RGS16 to alanines did not reduce GAP activity, we conclude that these positions are not positive design elements in RGS16 but rather play a specific role as negative design elements in the R12 subfamily. Finally, we showed that replacing these negative design elements in RGS18 with their counterparts from RGS16 led to a complete gain of function, further supporting our conclusions that these negative design elements attenuate GAP activity through interactions with the G helical domain.
More generally, our energy calculations and structural analysis provide insights into how RGS domains encode specificity toward G subunits. Although it was known that RGS interactions with the G GTPase domain are central to RGS GAP activity (1, 21, 48, 49) because the GTPase domain contains essentially all of the GTPbinding site, the functional roles of RGS interactions with the G helical domain were not clear. Our results show how contacts with the G helical domain can govern RGS-G interactions; a small number of key disruptor residues that interact with the G helical domain can fine-tune RGS GAP activity and determine specificity. Nevertheless, the interaction of these RGS modulatory residues with the G helical domain is not essential for high GAP activity, showing that these positions function as negative design elements only. Finally, the approach we used here can be leveraged to uncover additional positive and negative design elements across the larger RGS family and provide tools to rewire RGS interaction in cells and in vivo.
MATERIALS AND METHODS
Protein structures and sequences
We used the following 3D structures in our analysis and visualization of RGS-G complexes [with Protein Data Bank (PDB) codes for each structure]: rat RGS4-G i1 (PDB ID: 1AGR) (46), human RGS16 (hRGS16)-G i1 (PDB ID: 2IK8) (37), mouse RGS16 (mRGS16)-G o (PDB ID: 3C7K) (51), human RGS1-G i1 (PDB ID: 2GTP) (37), human RGS10-G i3 (PDB ID: 2IHB) (37) , and the monomeric nuclear magnetic resonance (NMR) structures of human RGS14 (PDB ID: 2JNU) and RGS18 (PDB ID: 2JM5) (37) . For visualization of the latter structures, we used the first model of the 20 NMR models in the PDB. 3D structural visualization and superimposition were performed with the molecular graphics program PyMOL (http://pymol.org). We used the following RGS domain sequences from the UniProt database (www.uniprot.org/): O43665 (RGS10), O14924 (RGS12), and O43566 (RGS14). Sequences were aligned using the T-Coffee server (http://tcoffee.vital-it.ch/apps/tcoffee/index.html), followed by manual adjustments in Jalview (www.jalview.org) according to our 3D structural comparisons. Data are means ± SEM of at least three independent biological replicates. Fig. 7 . Replacement of RGS18 disruptor residues with the corresponding RGS16 modulatory residues led to a gain of function. The k GAP constants for WT RGS18, the RGS18-to-RGS16 mutants Q186K and H156E-Q186K, and WT RGS16 were calculated as in described in Fig. 1 . Data are means ± SEM of at least three independent biological replicates.
Energy calculations to identify RGS residues that contribute substantially to the RGS-G interactions We followed a methodology described previously (18) to analyze the per-residue contributions of RGS residues to their G partner for the following crystal structures of RGS-G complexes (with PDB codes): human RGS16 (hRGS16)-G i1 (PDB ID: 2IK8), mouse RGS16 (mRGS16)-G o (PDB ID: 3C7K), RGS4-G i1 (PDB ID: 1AGR), and RGS1-G i1 (PDB ID: 2GTP). We used the FDPB method to calculate the G elec of each residue that is within 15 Å of the dimer interface. Residues that contributed substantially to the interaction were defined as those contributing G elec ≥ 1 kcal/mol to the interactions (twice the numerical error of the electrostatic calculations) (75) . G np were calculated as a surface-area proportional term by multiplying the per-residue surface area buried upon complex formation using surfv (76) by a surface tension constant of 0.05 kcal/mol per Å 2 (75) . Residues that contributed substantially to binding were defined as those contributing G np ≥ 0.5 kcal/mol to the interactions (namely, bury more than 10 Å 2 of each protein surface upon complex formation).
Protein expression, purification, and mutagenesis
The RGS4, RGS10, RGS14, RGS16, and RGS18 domains were expressed in the pLIC-SGC1 vector as N-terminally His 6 -tagged fusion proteins (Addgene). The N-terminally His 6 -tagged rat G o clone was a gift from V. Arshavsky (Duke University). RGS16 mutants were generated with the QuikChange site-directed mutagenesis kit (Invitrogen) with primers designed using the Primer Design Program (www. genomics.agilent.com). An RGS14-to-RGS16 chimera was also generated with the QuikChange site-directed mutagenesis kit by inserting the mutations T29E, E30A, K34T, A38E, R103D, Q105A, A119P, and V122L and by replacing regions Gln 76 to Pro
80
, Arg 85 to Asp 101 , and Leu 107 to Asn 111 with their RGS16 counterparts. Proteins were expressed in Escherichia coli BL21 (DE3) cells and grown in 0.5 or 1 liter of LB broth at 37°C for RGS or G proteins, respectively, until OD 600nm (optical density at 600 nm) ≥ 1.4 was reached. The temperature was then reduced to 15°C, and protein expression was induced by addition of 0.5 mM or 100 M isopropyl-d-thiogalactopyranoside for RGS or G proteins, respectively. After 16 to 18 hours, cells were harvested by centrifugation at 6000g for 30 min at 4°C, which was followed by freezing the pellets at −80°C. Bacterial pellets were suspended in lysis buffer [50 mM tris (pH 8.0), 50 mM NaCl, 5 mM MgCl 2 , 5 mM -mercaptoethanol, protease inhibitor cocktail (Roche), and 0.5 mM phenylmethylsulfonyl fluoride for G proteins only], and the cells were lysed with a Sonics Vibra-Cell sonicator, which was followed by centrifugation at 24,000g for 30 min at 4°C. The supernatants were equilibrated to 500 mM NaCl and 20 mM imidazole and loaded onto HisTrap FF 1-ml columns (GE Healthcare Life Sciences). The columns were washed with >20 volumes of wash buffer [20 mM tris (pH 8.0), 500 mM NaCl, and 20 mM imidazole] at 4°C, and the tagged proteins were eluted with elution buffer [20 mM tris (pH 8.0), 500 mM NaCl, and 100 mM imidazole (pH 8.0)]. The elute was loaded onto a HiLoad 16/600 Superdex 75 PG gel filtration column (GE Healthcare Life Sciences) at 4°C with ≥1.5 volumes of GF elution buffer [50 mM tris (pH 8.0), 50 mM NaCl, 5 mM -mercaptoethanol, and 1 mM MgCl 2 added for G subunits only]. The eluate was dialyzed against a dialysis buffer [GF elution buffer with 40% (v/v) glycerol]. All purified proteins were estimated to be >95% pure, as assessed by SDS-polyacrylamide gel electrophoresis and Coomassie staining. Protein concentrations were determined by measuring their absorption at 280 nm using the predicted extinction coefficients (ProtParam, Swiss Institute for Bioinformatics) of the sequence of each expressed protein.
Single-turnover GTPase assays
Single-turnover GTPase assays using G o and the various RGS proteins were performed, as detailed in previous studies (18, 48, 63, 64) . Briefly, G o in reaction buffer [50 mM Hepes (pH 7.5), 0.05% (v/v) polyoxyethylene, 5 mM EDTA, bovine serum albumin (5 mg/ml), and 1 mM dithiothreitol] was incubated for 15 min at 20°C with 1 mM [- 32 P]GTP and cooled on ice for 5 min. GTP hydrolysis was initiated by increasing the magnesium concentration to 5 mM (with MgCl 2 ), together with 100 M cold GTP (final concentration) with or without RGS proteins at 4°C. Aliquots were taken at different time points and were quenched with 5% charcoal in 50 mM Na 2 H 2 PO 4 (pH 3) on ice, which was followed by centrifugation at 12,000g for 5 min at room temperature. The supernatant (200 l) was transferred to 3 ml of liquid scintillation liquid (PerkinElmer) and analyzed with a Tri-Carb 2810 TR scintillation counter (PerkinElmer). GTPase rates were determined from single-exponential fits to the time courses using SigmaPlot 10.0. We calculated k GAP rate constants by subtracting the basal GTPase rate (without RGS protein) from the GTPase rate that was measured in the presence of the RGS protein, as described previously (64) .
RGS dose-response analysis
RGS dose-response analysis was performed as in previous studies (52, 65) . G o was loaded with 1 mM [- 32 P]GTP for 15 min at 20°C in reaction buffer and then cooled on ice for 5 min. Each assay was initiated by adding 10 l of RGS protein in different concentrations in assay buffer (5 mM MgCl 2 and 100 M cold GTP) to a tube containing 20 l of G o subunit (500 nM) on ice. Each reaction was terminated after 45 s by adding 100 l of 5% perchloric acid and quenching with 700 l of 10% (w/v) charcoal slurry in 50 mM phosphate buffer (pH 7.5), which was followed by centrifugation at 12,000g for 5 min at room temperature. The supernatant (200 l) was transferred to 3 ml of liquid scintillation and analyzed with a Tri-Carb 2810 TR scintillation counter (PerkinElmer). EC 50 values were determined from three-parameter sigmoidal curves with Sigma Plot 10.0.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/11/534/eaan3677/DC1 Fig. S1 . The RGS interface with G subunits is predominantly electrostatic and polar. Fig. S2 . A pair of RGS1 and RGS4 residues contributes favorably to electrostatic interactions with the G helical domain. Fig. S3 . A chimera of RGS14 and RGS16 exhibits increased GAP activity.
